Farabi Pharmaceutical (XTEH:DFRB1) Inventories, Raw Materials & Components: IRR0.00 Mil (As of . 20)


What is Farabi Pharmaceutical Inventories, Raw Materials & Components?

Farabi Pharmaceutical XTEH:DFRB1 Inventories, Raw Materials & Components is IRR0.00 Mil as of . 20.

Farabi Pharmaceutical's inventories, raw materials & components for the quarter that ended in . 20 was IRR0.00 Mil.

Farabi Pharmaceutical Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Inventories, Raw Materials & Components Chart

Farabi Pharmaceutical Annual Data
Trend
Inventories, Raw Materials & Components

Farabi Pharmaceutical Quarterly Data
Inventories, Raw Materials & Components

Farabi Pharmaceutical Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of IRR0.00 Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Inventories, Raw Materials & Components of IRR0.00 Mil as of . 20. Raw materials are the components a company uses for its main products. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Inventories, Raw Materials & Components too high?
Farabi Pharmaceutical's current Inventories, Raw Materials & Components is IRR0.00 Mil.
How does Farabi Pharmaceutical's Inventories, Raw Materials & Components compare to IMNPQ and INNV?
Farabi Pharmaceutical's Inventories, Raw Materials & Components of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current Inventories, Raw Materials & Components is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Inventories, Raw Materials & Components of IRR0.00 Mil. The current Inventories, Raw Materials & Components is IRR0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Inventories, Raw Materials & Components is IRR0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.